European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on November 4, 2026

Nov. 4, 2026

How to Choose a Reliable Red Light Therapy Manufacturer: A B2B Buyer Checklist

Indeterminate EIN Presswire

Nov. 4, 2026

Top 5 Chemicals from a Chinese Chemical Manufacturer: Xingfei's Products Fits the Needs

Indeterminate EIN Presswire

Nov. 4, 2026

Turismo Costa del Sol invests €1.5 million in the UK market to encourage longer stays at the destination

Indeterminate EIN Presswire

Nov. 4, 2026

Five Reputable Heat Treatment Furnaces Companies in China 2026: Advancing Intelligent Manufacturing

Indeterminate EIN Presswire

Nov. 4, 2026

Agomab to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 4, 2026

Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates

Indeterminate GlobeNewswire

Nov. 4, 2026

PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

Indeterminate GlobeNewswire

Nov. 4, 2026

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 4, 2026

Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Nov. 4, 2026

Alamar Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 4, 2026

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Revolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire

Nov. 4, 2026

Stellantis Appoints Pablo Di Si Chief Operating Officer, North America and American Brands

Indeterminate GlobeNewswire

Nov. 4, 2026

BioCryst to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 4, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 4, 2026

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 4, 2026

Celldex to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 4, 2026

Arvinas to Present Preliminary Clinical Data from Early Monotherapy Dose Escalation Cohorts in the Phase 1 Trial for ARV-393 (Zaloblideg), a PROTAC BCL6 Degrader, at the 2026 American Society of Hematology (ASH®) Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Xceptor appoints Keith Redmond as CTO to drive the next phase of AI-driven transformation

Indeterminate EIN Presswire